Table 13. The anti-ZIKV activity of the compounds 204–206.
| Compd | ZIKV reporter assay | Titer reduction assay | CC50 (μM) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Inhibition (%) at 10 μM | Viability (%) at 10 μM | EC50 (μM) | % at 8.5 μM | % at 1.5 μM | EC50 (μM) | EC90 (μM) | EC99 (μM) | ||
| 204 | 73 | 69 | 5.25 | 93 | — | 5.21 | 10.7 | — | 20.0 |
| 205 | 78 | 68 | 4.10 | 97 | 47 | 4.29 | 9.02 | 13.6 | 20.6 |
| 206 | 90 | 60 | 3.16 | 99 | — | 5.05 | 6.98 | 12.7 | 5.3 |